文献速递神经肿瘤

脑肿瘤患者围手术期类固醇给药实践差异:一项国际调查

Practice Variation in Perioperative Steroid Dosing for Brain Tumor Patients: An International Survey.
PubMed 文献 · World Neurosurg · 2021-12-24

该国际电子调查于2019年12月6日至2020年6月1日通过欧洲神经外科学会及社交媒体发放,共获得来自55个国家6大洲175名神经外科医生的回复。130名(80%)受访者表示会在围手术期处方类固醇,剂量范围为2至64 mg/天,给药方案为每日1至4次,最常用为地塞米松16 mg/天(49人;31%)、12 mg/天(31人;20%)和8 mg/天(18人;12%)。处方剂量与医生及机构特征之间未发现显著关联。

要点

  • 130名(80%)受访神经外科医生在脑肿瘤患者围手术期处方类固醇。
  • 报告剂量范围为2至64 mg/天,给药频率为每日1至4次。
  • 最常用为地塞米松16 mg/天(49人;31%)、12 mg/天(31人;20%)、8 mg/天(18人;12%)。

核心结论

  • 类固醇在脑肿瘤患者围手术期常被处方,但神经外科医生之间的剂量和给药方案存在很大实践差异。
  • 需要以 prospective 且最好随机的方式进一步研究,以确定最佳给药方案并实施国际/国家类固醇使用指南。

研究设计与样本

  • 电子调查包含27个关于类固醇剂量、减量方案和不良事件的问题,于2019年12月6日至2020年6月1日发放给神经外科医生。
  • 调查通过欧洲神经外科学会(European Association of Neurosurgical Societies)和社交媒体平台分发。
  • 共获得来自55个国家6大洲的175份回复,包括来自低收入或中等收入国家的30份;152名(87%)受访者完成所有问题。

主要发现

  • 130名(80%)受访者表示处方围手术期类固醇;报告剂量范围为2至64 mg/天,给药方案为每日1至4次。
  • 最常处方的类固醇为地塞米松,剂量为16 mg/天(n=49;31%)、12 mg/天(n=31;20%)和8 mg/天(n=18;12%)。
  • 处方剂量与医生及机构特征之间未发现显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Steroids are commonly used to treat peritumoral edema and increased intracranial pressure in patients with brain tumors. Despite widespread use of steroids, relatively little evidence is available about their optimal perioperative dosing scheme. This study aimed to increase insight into practice variation of perioperative steroid dosing and tapering schedules used in the neurosurgical community. METHODS: An electronic survey comprising 27 questions regarding steroid dosing, tapering schedules, and adverse events was administered to neurosurgeons between December 6, 2019, and June 1, 2020. The survey was distributed through the European Association of Neurosurgical Societies and social media platforms. Collected data were assessed for quantitative and qualitative analysis. RESULTS: The survey obtained 175 responses from 55 countries across 6 continents, including 30 from low- or middle-income countries; 152 (87%) respondents completed all questions. Of respondents, 130 (80%) indicated prescribing perioperative steroids. Reported doses ranged from 2 to 64 mg/day in schedules ranging from 1 to 4 times daily. The most prescribed steroid was dexamethasone in doses of 16 mg/day (n = 49; 31%), 12 mg/day (n = 31; 20%), and 8 mg/day (n = 18; 12%). No significant association was found between prescribed dose and physician and institutional characteristics. CONCLUSIONS: Steroids are commonly prescribed perioperatively in patients with brain tumors. However, there is great practice variation in dosing and schedules among neurosurgeons. Future investigation in a prospective and preferably randomized manner is needed to identify an optimal dosing scheme and implement international/national guidelines for steroid use.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Jessurun CAC, Hulsbergen AFC, Lamba N, et al. Practice Variation in Perioperative Steroid Dosing for Brain Tumor Patients: An International Survey. World Neurosurg. 2021. PMID: 34958992. doi:10.1016/j.wneu.2021.12.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。